ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
228.00
-13.00 (-5.39%)
Sep 24, 2026, 2:59 PM CST

ACRO Biomedical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
16,3444,0401,5642,4091,024939
Market Cap Growth
270.29%158.32%-35.07%135.16%9.09%-
Enterprise Value
15,4613,6001,0512,150691860
Last Close Price
228.0066.0025.2838.9419.6924.61

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
309.79105.6235.3647.1837.0743.02
PB Ratio
15.343.662.503.512.717.22
P/TBV Ratio
15.433.682.523.562.767.69

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
293.0594.1123.7542.1125.0139.40

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.010.030.030.030.10
Net Debt / Equity Ratio
-0.83-0.88-0.77-0.81-0.81-0.38
Net Debt / EBITDA Ratio
10.5011.838.3012.765.271.05
Net Debt / FCF Ratio
10.8315.656.548.066.391.03
Asset Turnover
0.060.040.060.090.100.12
Inventory Turnover
1.371.691.791.091.050.52
Quick Ratio
60.4849.9027.5839.6625.826.11
Current Ratio
62.2851.1228.6841.0427.689.01
Return on Equity (ROE)
-9.57%-9.55%-9.46%-7.78%-23.94%-32.92%
Return on Assets (ROA)
-6.84%-6.45%-5.89%-5.46%-14.27%-18.87%
Return on Capital Employed (ROCE)
-8.60%-8.30%-10.20%-6.90%-16.30%-38.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.48%-2.05%-3.97%-1.72%-5.94%-5.41%
FCF Yield
-0.50%-1.53%-4.73%-2.88%-4.67%-5.13%
Buyback Yield / Dilution
-8.21%-0.04%-16.17%-11.22%-33.71%-17.22%